share_log

七牛云、药明合联、速腾聚创、同日集团等4家拟香港/美国IPO上市,在中国证监会备案(07.27)

Four companies, including Qiniuyun, Pharmaceutical Federation, Suteng Juchuang, and Dongni Group, plan to go public in a Hong Kong/US IPO and file with the China Securities Regulatory Commission (07.27)

瑞恩資本RyanbenCapital ·  Jul 30, 2023 12:57

Status of overseas securities issued by domestic companies and listing registration (July 27, 2023)

On July 27, the China Securities Regulatory Commission announced the overseas issuance of securities and listing records by domestic companies (initial public offerings and full circulation). This week, 4 new companies (1 US IPO, 3 Hong Kong IPO) have been added. Up to now, 105 filings have been announced, including 24 proposed US IPO listed companies since the filing system (1 of which has obtained a filing notice), and a total of 74 companies planning to file an IPO in Hong Kong (9 of which have obtained a US listing notice, 1 listed company with a Hong Kong listing termination filing), 1 listed company in Hong Kong Registration of acquisitions involving Chinese assets; full circulation of 6 companies Filing (all have obtained a filing notice). The 4 new furniture items added this week are as follows:

The 3 new companies to be listed in Hong Kong were added this week as follows:

Qiniuyun

Qiniu Intelligent Technology Co., Ltd Qiniu Limited (abbreviation”Qiniuyun”), submitted a prospectus on the Hong Kong Stock Exchange on June 29, 2023, to be IPO listed on the Hong Kong Main Board.

QiniuyunThe application type is indirect overseas listing. The filing entity is Shanghai Qiniu Information Technology Co., Ltd., and the filing date is July 21, 2023. Shen Wan Hongyuan and BOB International are its co-sponsors, and KWM is their domestic lawyer.

QiniuyunEstablished in 2011, as one of the first platforms to provide audio and video cloud services in China, it strives to become the world's leading one-stop scenario-based intelligent audio and video service provider. The company mainly provides audio and video PaaS (mPaaS) services and application platform as a service (APaaS). The company is one of the few companies in China that has developed comprehensive and high-performance MPaaS products and has the technical capabilities to integrate and cover all aspects of the audio and video business. According to iResearch, in terms of revenue in 2022,QiniuyunIt is the third largest audio and video PaaS (mPaaS) service provider in China, with a market share of 5.7%; in terms of APaaS (application platform as a service) revenue in 2022,QiniuyunIt is also the second largest audio and video APaaS service provider in China, with a market share of 11.9%. According to iResearch,QiniuyunIt is one of the few audio and video PaaS providers that has mastered comprehensive AI capabilities, and is also one of the first audio and video PaaS providers with the ability to apply development components of big language models to audio and video cloud services.QiniuyunThe AI service capabilities provided include intelligent vision, intelligent voice, intelligent editing, industry algorithms, content security, and business security.

Qi Niuyun abandoned the US and went to Hong Kong and submitted a prospectus for a Hong Kong IPO listing. Shen Wan Hongyuan and BOCOM International jointly endorsed it

Link to the Qiniuyun prospectus:

HKEXNEWS.hk/app...

Pharmacology Joint Federation

Yakuming Joint Biotechnology Co., Ltd. WuXi XDC Cayman Inc.(hereafter referred to as”Pharmacology Joint Federation”), submitted a prospectus on the Hong Kong Stock Exchange on July 9, 2023, to be IPO listed on the Hong Kong Main Board.

Pharmacology Joint FederationThe application type is indirect overseas listing. The filing entity is Wuxi Pharmaceutical Joint Federation Biotechnology Co., Ltd., and the filing date is July 24, 2023. Morgan Stanley, Goldman Sachs, and J.P. Morgan Chase are its co-sponsors, and Fangda is its domestic lawyer.

Pharmacology Joint FederationAs a leading CRDMO (contract research, development and manufacturing organization) focusing on the global ADC and broader bioconjugated drug market, it is also the only company dedicated to providing comprehensive end-to-end services. According to Frost & Sullivan's data, in 2022 in terms of revenue,Pharmacology Joint FederationIt is the second largest CRDMO in the world engaged in bioconjugated drugs such as ADC (antibody-drug conjugates); in terms of the total number of projects up to the end of 2022,Pharmacology Joint FederationIt is the world's largest bioconjugated drug CRDMO.

On the last practical date,Beautiful natureTwo leading large-scale specialized industrial parks in Anhui Province (i.e.Mio Industrial Park,Jiasheng Industrial Park) Provides industrial wastewater treatment services. On the last practical date, the company also had companies in Anhui and Hebei13Domestic sewage treatment projects are carried out according to the franchise model. Furthermore, the company completed during the track record period22The design and construction of domestic sewage treatment projects.

Yao Ming joined forces to split from “Yao Ming Biotech” and submitted a prospectus for IPO listing in Hong Kong

Link to the prospectus of the Pharmaceutical and Ming Joint Federation:

HKEXNEWS.hk/app...

Suteng Juchuang

ROBOSENSE TECHNOLOGY CO., LTD(abbreviation”Suteng Juchuang”), submitted a prospectus on the Hong Kong Stock Exchange on June 30, 2023, to be IPO listed on the Hong Kong Main Board.

Suteng JuchuangThe application type is indirect overseas listing. The filing subject is Shenzhen Suteng Juchuang Technology Co., Ltd., and the filing date is July 24, 2023. J.P. Morgan Chase and Huaxing Securities are its co-sponsors, and Han Kun is their domestic lawyer.

Suteng JuchuangEstablished in 2014, as a global leader in the lidar and sensing solutions market, the company mainly forms solutions based on chip-driven lidar hardware and also lays out artificial intelligence sensing software technology. From its establishment until March 31, 2023,Suteng JuchuangOver 100,000 lidars have been delivered.Suteng JuchuangThe revenue comes from selling various lidar hardware to customers in the automotive, robotics, and other industries, and providing customers with lidar sensing solutions that combine products and services (including lidar hardware, software, and related services). According to Insight Consulting, Suteng Juchuang is the first lidar company in the world to achieve mass production of automotive-grade solid-state lidar. Lidar products have been selected by 9 of the top 10 automakers in China according to sales volume in 2022, including China's largest automobile manufacturer and the world's largest new energy vehicle manufacturer. In addition, cooperative relationships have been established with more than 200 automotive automakers and Tier 1 suppliers around the world; as of March 31, 2023, outside of the automotive industry (agricultural robots, inspection robots, V2X solutions, and sensing solutions, etc.), Suteng Juchuang has served about 2,000 customers, and the cumulative sales volume of robots and other non-automotive customers is the highest in the world.

Suteng Juchuang RoboSense submitted a prospectus for IPO listing in Hong Kong. Cainiao, Geely, Xiaomi, Fosun, Yutong, etc. participated in shares

Link to Suteng Juchuang's prospectus:

HKEXNEWS.hk/app...

One company to be listed in the US is as follows:

Tungray Technologies (Same Day Group)

TUNGRAY TECHNOLOGIES INC(hereafter referred to as”SAME DAY GROUP”), it publicly disclosed its prospectus to the SEC on March 7, 2023, to be IPO listed on the NASDAQ, stock code TRSG.

SAME DAY GROUPThe application type is indirect overseas listing. The filing entity is Tongsheng Smart Equipment (Shenzhen) Co., Ltd., and the filing date is July 26, 2023. Tiger Securities is its underwriter, and Han Kun is its domestic lawyer.

TUNGRAY, headquartered in Singapore, as a contract design company, provides customized industrial manufacturing solutions for OEM equipment manufacturers in the semiconductor, printer, electronics, and household appliances industries. The company has R&D and production bases in Singapore, as well as production bases in Qingdao and Shenzhen in China. In 2021, revenue from Singapore and China accounted for 61.1% and 38.9% respectively.TUNGRAYWe provide comprehensive ETO services to design, build, and build industrial manufacturing solutions for various quality control, product manufacturing, and product testing processes. The company has about 20 years of experience in motor control, sensor technology, computer and overall vision product design, and can provide solutions that meet customer specifications. The Singaporean subsidiary is the main location for core activities, including the research, development and coordination of solution prototypes, while the Chinese subsidiary provides manufacturing support for necessary component production or provides certain services for large-scale solution manufacturing procurement. TUNGRAYAlsoWe provide products such as linear motors, precision linear motor modules, and high-frequency induction welding equipment.

Tunggray Group, which accounts for nearly 40% of revenue from the mainland, has submitted a prospectus with the US SEC and plans to go public on the NASDAQ IPO

Link to the Group's prospectus for the same day:

https://www.sec.gov/Archives/edgar/data/1943444/000157587223000342/rc019_f1.htm****b_034

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment